首页> 外文期刊>老年心脏病学杂志(英文版) >Telemonitoring and hemodynamic monitoring to reduce hospitalization rates in heart failure: a systematic review and meta-analysis of randomized controlled trials and real-world studies
【24h】

Telemonitoring and hemodynamic monitoring to reduce hospitalization rates in heart failure: a systematic review and meta-analysis of randomized controlled trials and real-world studies

机译:远程监测和血液动力学监测可降低心力衰竭的住院率:随机对照试验和实际研究的系统回顾和荟萃分析

获取原文
获取原文并翻译 | 示例
       

摘要

Background Heart failure is a significant problem leading to repeated hospitalizations.Telemonitoring and hemodynamic monitoring have demonstrated success in reducing hospitalization rates,but not all studies reported significant effects.The aim of this systematic review and meta-analysis is to examine the effectiveness of telemonitoring and wireless hemodynarnic monitoring devices in reducing hospitalizations in heart failure.Methods & Results PubMed and Cochrane Library were searched up to 1st May 2017 for articles that investigated the effects oftelemonitoring or hemodynamic monitoring on hospitalization rates in heart failure.In 31,501 patients (mean age:68 + 12 years;61% male;follow-up 11 ± 8 months),telemonitoring reduced hospitalization rates with a HR of 0.73 (95% CI:0.65-0.83;P < 0.0001) with significant heterogeneity (I2=94%).These effects were observed in the short-term (≤ 6 months:HR =0.77,95% CI:0.65-0.89;P < 0.01) and long-term (≥ 12 months:HR =0.73,95% CI:0.62-0.87;P < 0.0001).In 4831 patients (mean age 66 ± 18 years;66% male;follow-up 13 ± 4 months),wireless hemodynamic monitoring also reduced hospitalization rates with a HR of 0.60 (95% CI:0.53-0.69;P < 0.001) with significant heterogeneity (I2=64%).This reduction was observed both in the short-term (HR =0.55,95% CI:0.45-0.68;P < 0.001;I2 =72%) and long-term (HR=0.64,95% CI:0.57-0.72;P < 0.001;I2=55%).Conclusions Telemonitoring and hemodynamic monitoring reduce hospitalization in both short-and long-term in heart failure patients.
机译:背景技术心力衰竭是导致反复住院的重要问题。远程监护和血流动力学监测已证明在降低住院率方面取得了成功,但并非所有研究都报告了显着效果。本系统综述和荟萃分析的目的是检验远程监护的有效性。方法和结果截至2017年5月1日,在PubMed和Cochrane图书馆中检索了研究心电图监测或血液动力学监测对心力衰竭住院率的影响的文章。在31,501名患者中(平均年龄:68岁) + 12岁; 61%男性;随访11±8个月),监护减少了住院率,HR为0.73(95%CI:0.65-0.83; P <0.0001),异质性很强(I2 = 94%)。短期(≤6个月:HR = 0.77,95%CI:0.65-0.89; P <0.01)和长期(≥12个月:HR = 0.73,95%CI:0.62-0.87)观察到效果; P <0 .0001)。在4831例患者中(平均年龄66±18岁;男性66%;随访13±4个​​月),无线血流动力学监测还降低了住院率,HR为0.60(95%CI:0.53-0.69; P <0.001),异质性显着(I2 = 64%)。短期(HR = 0.55,95%CI:0.45-0.68; P <0.001; I2 = 72%)和长期(HR = 0.55,95%CI:0.45-0.68; HR = 0.64,95%CI:0.57-0.72; P <0.001; I2 = 55%)。结论远程监测和血流动力学监测可减少心衰患者的短期和长期住院率。

著录项

  • 来源
    《老年心脏病学杂志(英文版)》 |2018年第4期|298-309|共12页
  • 作者单位

    Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China;

    Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China;

    Department of Cardiovascular Medicine, the First Affiliated Hospital of Dalian Medical University, Dalian, China;

    Auckland Bioengineering Institute, the University of Auckland, Auckland, New Zealand;

    Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China;

    Department of Clinical Research, Federal University of Uberl(a)ndia, Uberl(a)ndia, MG, Brazil;

    JC School of Public Health and Primary Care, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, China;

    Division of Cardiology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada;

    Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China;

    Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China;

    Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China;

    Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin, China;

    State Key Laboratory of Cardiovascular Disease, Heart Failure Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China;

    Department of Cardiology, Qinghai Provincial People's Hospital, Xining, China;

    Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran;

    Division of Cardiology, State University of New York at Buffalo, Buffalo, NY, USA;

    The Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, Athens, Greece;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:37:57
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号